Slides and webcasts from all ESMO Advanced courses are open to all, ESMO Members and ESMO Account holders, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Advanced Course on Biomarkers for Precision Medicine 2021: Zurich
- Start date
- 12 Nov 2021
- End date
- 13 Nov 2021
- Location
- Zurich, Switzerland
Learning objectives
- To recognize the different modalities of molecular assays needed for contemporary practice of precision oncology.
- To determine the different technologies available for biomarker testing and the context where these technologies are most effective, depending on the nature of the biomarker and the availability of biological samples.
- To comprehend the different modalities of cfDNA testing and their applications in disease monitoring, development of resistance and minimal residual disease assessment.
- To recognize the applications of multiplex immunophenotyping, spatial transcriptomics and artificial intelligence applied to tissue samples.
- To define the contribution of multidisciplinary teams and tumour boards for therapy decision making.
Accreditation
The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Federica Di Nicolantonio, Italy
- Jorge Reis-Filho, United States
Supported by
